Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival
- C. Rastellini
- , A. Salam
- , R. Kuddus
- , A. Aitouche
- , V. Subbotin
- , M. Braun
- , R. Leach
- , R. Peach
- , J. J. Fung
- , T. E. Starzl
- , A. S. Rao
Research output: Contribution to journal › Article › peer-review
13
Link opens in a new tab
Scopus
citations